Vascular resection and reconstruction for pancreatic malignancy: A single center survival study

Mohammad Al-Haddad, J. Kirk Martin, Justin H Nguyen, Surakit Pungpapong, Massimo Raimondo, Timothy Woodward, George Kim, Kyung Noh, Michael B. Wallace

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Introduction: Pancreatic cancer is one of the leading causes of cancer-related death in the USA. Recently, several centers have introduced portal and superior mesenteric vein resection and reconstruction during extended pancreatectomy, rendering the previously inoperable cases resectable. Aim: The aim of this study is to confirm whether patients with locally advanced pancreatic cancer and mesenteric vascular invasion can be cured with extended pancreatectomy with vascular reconstruction (VR) and to compare their survival to patients treated with pancreatectomy without VR and those treated without resection (palliation). Methods: Survival of 22 patients who underwent pancreatectomy with VR was compared with two control groups: 54 patients who underwent pancreatectomy without the need for VR and 28 patients whose pre-operative imaging suggested resectability but whose laparotomy indicated inoperability. Results: A slight survival benefit was noted in patients who did not require VR (33.5%) compared to those who did require VR [20%, p = 0.18], although not reaching statistical significance. Despite a low 15% three-year survival in patients treated palliatively, this was not statistically different compared to survival after resection with VR (P = 0.23). The presence of nodal metastasis was associated with worse survival (p = 0.006), and the use of adjuvant therapy was associated with better survival (p = 0.001). Conclusion: Pancreatic cancers that require VR to completely resect the tumor have a similar survival to those not requiring VR. Long-term survival was achievable in approximately 1 out 5 patients requiring VR, although we were not able to demonstrate statistically improved survival compared to palliative care.

Original languageEnglish (US)
Pages (from-to)1168-1174
Number of pages7
JournalJournal of Gastrointestinal Surgery
Volume11
Issue number9
DOIs
StatePublished - Sep 2007

Fingerprint

Blood Vessels
Survival
Pancreatectomy
Neoplasms
Pancreatic Neoplasms
Mesenteric Veins
Palliative Care
Laparotomy
Neoplasm Metastasis
Control Groups

Keywords

  • Pancreatic cancer
  • Post operative survival
  • Vascular reconstruction

ASJC Scopus subject areas

  • Surgery

Cite this

Vascular resection and reconstruction for pancreatic malignancy : A single center survival study. / Al-Haddad, Mohammad; Martin, J. Kirk; Nguyen, Justin H; Pungpapong, Surakit; Raimondo, Massimo; Woodward, Timothy; Kim, George; Noh, Kyung; Wallace, Michael B.

In: Journal of Gastrointestinal Surgery, Vol. 11, No. 9, 09.2007, p. 1168-1174.

Research output: Contribution to journalArticle

Al-Haddad, Mohammad ; Martin, J. Kirk ; Nguyen, Justin H ; Pungpapong, Surakit ; Raimondo, Massimo ; Woodward, Timothy ; Kim, George ; Noh, Kyung ; Wallace, Michael B. / Vascular resection and reconstruction for pancreatic malignancy : A single center survival study. In: Journal of Gastrointestinal Surgery. 2007 ; Vol. 11, No. 9. pp. 1168-1174.
@article{0fbd0f4193f14c929fb098cc89278234,
title = "Vascular resection and reconstruction for pancreatic malignancy: A single center survival study",
abstract = "Introduction: Pancreatic cancer is one of the leading causes of cancer-related death in the USA. Recently, several centers have introduced portal and superior mesenteric vein resection and reconstruction during extended pancreatectomy, rendering the previously inoperable cases resectable. Aim: The aim of this study is to confirm whether patients with locally advanced pancreatic cancer and mesenteric vascular invasion can be cured with extended pancreatectomy with vascular reconstruction (VR) and to compare their survival to patients treated with pancreatectomy without VR and those treated without resection (palliation). Methods: Survival of 22 patients who underwent pancreatectomy with VR was compared with two control groups: 54 patients who underwent pancreatectomy without the need for VR and 28 patients whose pre-operative imaging suggested resectability but whose laparotomy indicated inoperability. Results: A slight survival benefit was noted in patients who did not require VR (33.5{\%}) compared to those who did require VR [20{\%}, p = 0.18], although not reaching statistical significance. Despite a low 15{\%} three-year survival in patients treated palliatively, this was not statistically different compared to survival after resection with VR (P = 0.23). The presence of nodal metastasis was associated with worse survival (p = 0.006), and the use of adjuvant therapy was associated with better survival (p = 0.001). Conclusion: Pancreatic cancers that require VR to completely resect the tumor have a similar survival to those not requiring VR. Long-term survival was achievable in approximately 1 out 5 patients requiring VR, although we were not able to demonstrate statistically improved survival compared to palliative care.",
keywords = "Pancreatic cancer, Post operative survival, Vascular reconstruction",
author = "Mohammad Al-Haddad and Martin, {J. Kirk} and Nguyen, {Justin H} and Surakit Pungpapong and Massimo Raimondo and Timothy Woodward and George Kim and Kyung Noh and Wallace, {Michael B.}",
year = "2007",
month = "9",
doi = "10.1007/s11605-007-0216-x",
language = "English (US)",
volume = "11",
pages = "1168--1174",
journal = "Journal of Gastrointestinal Surgery",
issn = "1091-255X",
publisher = "Springer New York",
number = "9",

}

TY - JOUR

T1 - Vascular resection and reconstruction for pancreatic malignancy

T2 - A single center survival study

AU - Al-Haddad, Mohammad

AU - Martin, J. Kirk

AU - Nguyen, Justin H

AU - Pungpapong, Surakit

AU - Raimondo, Massimo

AU - Woodward, Timothy

AU - Kim, George

AU - Noh, Kyung

AU - Wallace, Michael B.

PY - 2007/9

Y1 - 2007/9

N2 - Introduction: Pancreatic cancer is one of the leading causes of cancer-related death in the USA. Recently, several centers have introduced portal and superior mesenteric vein resection and reconstruction during extended pancreatectomy, rendering the previously inoperable cases resectable. Aim: The aim of this study is to confirm whether patients with locally advanced pancreatic cancer and mesenteric vascular invasion can be cured with extended pancreatectomy with vascular reconstruction (VR) and to compare their survival to patients treated with pancreatectomy without VR and those treated without resection (palliation). Methods: Survival of 22 patients who underwent pancreatectomy with VR was compared with two control groups: 54 patients who underwent pancreatectomy without the need for VR and 28 patients whose pre-operative imaging suggested resectability but whose laparotomy indicated inoperability. Results: A slight survival benefit was noted in patients who did not require VR (33.5%) compared to those who did require VR [20%, p = 0.18], although not reaching statistical significance. Despite a low 15% three-year survival in patients treated palliatively, this was not statistically different compared to survival after resection with VR (P = 0.23). The presence of nodal metastasis was associated with worse survival (p = 0.006), and the use of adjuvant therapy was associated with better survival (p = 0.001). Conclusion: Pancreatic cancers that require VR to completely resect the tumor have a similar survival to those not requiring VR. Long-term survival was achievable in approximately 1 out 5 patients requiring VR, although we were not able to demonstrate statistically improved survival compared to palliative care.

AB - Introduction: Pancreatic cancer is one of the leading causes of cancer-related death in the USA. Recently, several centers have introduced portal and superior mesenteric vein resection and reconstruction during extended pancreatectomy, rendering the previously inoperable cases resectable. Aim: The aim of this study is to confirm whether patients with locally advanced pancreatic cancer and mesenteric vascular invasion can be cured with extended pancreatectomy with vascular reconstruction (VR) and to compare their survival to patients treated with pancreatectomy without VR and those treated without resection (palliation). Methods: Survival of 22 patients who underwent pancreatectomy with VR was compared with two control groups: 54 patients who underwent pancreatectomy without the need for VR and 28 patients whose pre-operative imaging suggested resectability but whose laparotomy indicated inoperability. Results: A slight survival benefit was noted in patients who did not require VR (33.5%) compared to those who did require VR [20%, p = 0.18], although not reaching statistical significance. Despite a low 15% three-year survival in patients treated palliatively, this was not statistically different compared to survival after resection with VR (P = 0.23). The presence of nodal metastasis was associated with worse survival (p = 0.006), and the use of adjuvant therapy was associated with better survival (p = 0.001). Conclusion: Pancreatic cancers that require VR to completely resect the tumor have a similar survival to those not requiring VR. Long-term survival was achievable in approximately 1 out 5 patients requiring VR, although we were not able to demonstrate statistically improved survival compared to palliative care.

KW - Pancreatic cancer

KW - Post operative survival

KW - Vascular reconstruction

UR - http://www.scopus.com/inward/record.url?scp=34548119149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548119149&partnerID=8YFLogxK

U2 - 10.1007/s11605-007-0216-x

DO - 10.1007/s11605-007-0216-x

M3 - Article

C2 - 17632763

AN - SCOPUS:34548119149

VL - 11

SP - 1168

EP - 1174

JO - Journal of Gastrointestinal Surgery

JF - Journal of Gastrointestinal Surgery

SN - 1091-255X

IS - 9

ER -